Nedd8 Regulation of Ubiquitin E3 Ligases in Adipocytes
Nedd8 对脂肪细胞中泛素 E3 连接酶的调节
基本信息
- 批准号:7140286
- 负责人:
- 金额:$ 20.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-07-15 至 2008-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Morbid and childhood obesity are characterized by excessive accumulation of adipose-tissue mass that results from enlargement of existing differentiated adipocytes (hypertrophic obesity) and from acquisition of new adipocytes from proliferation and subsequent differentiation of preadipocytes (hyperplastic obesity). Considering the rapid rise in childhood obesity and the devastating long term heath implications to these individuals, it has become critically important to gain greater knowledge of the molecular mechanisms regulating adipocyte hyperplasia. For several years, our lab has focused on the regulation and function of cyclin-dependent kinase (CDK) inhibitors, such as p27 and p21 that control G1 to S phase progression of the cell cycle as molecular regulators of preadipocyte replication. Preliminary data of this proposal demonstrate a physiological roll for the SCFSkp2 E3 ligase in mediating polyubiquitylation and degradation of p27 by the 26S proteasome during adipocyte hyperplasia. Furthermore, our preliminary data demonstrate that Cul1, a protein subunit of the SCF E3 ligase, is modified by the ubiquitin-like molecule Nedd8 in adipocytes and that the extent of Nedd8-Cul1 conjugates is regulated during G1 phase progression under physiological conditions. Based on these data and published literature, we developed the central hypothesis that Nedd8 modification of the SCF E3 ligase is a dynamic process that involves opposing pathways that attach and remove Nedd8 from its cullin protein target and that both pathways are essential for ubiquitin-mediated p27 protein degradation and adipocyte hyperplasia. We will test the central hypothesis in two aims. The first explores the physiological significance and mechanism of regulated Nedd8 modification during G1 phase progression regarding E3 ligase activity. The second determines the role of the CSN as a Nedd8 isopeptidase capable of removing Nedd8 and the impact regarding cellular SCF activity. Both aims address mechanisms linking attachment and removal of Nedd8 through evaluation of testable working models. We predict that pathways responsible for adding and removing Nedd8 are essential for SCF E3 ligase activity, p27 ubiquitylation and degradation, and adipocyte hyperplasia.
描述(由申请人提供):病态和儿童肥胖症的特征在于脂肪组织质量的过度积累,这是由现有分化的脂肪细胞的增大(肥大性肥胖症)和由前脂肪细胞的增殖和随后的分化获得新的脂肪细胞(增生性肥胖症)引起的。考虑到儿童肥胖症的迅速增加和对这些个体的破坏性长期健康影响,获得更多关于调节脂肪细胞增生的分子机制的知识变得至关重要。几年来,我们的实验室一直专注于细胞周期蛋白依赖性激酶(CDK)抑制剂的调节和功能,如p27和p21,作为前脂肪细胞复制的分子调节剂,控制细胞周期的G1期到S期进程。该提议的初步数据表明,在脂肪细胞增生过程中,SCFSkp 2 E3连接酶在介导26 S蛋白酶体对p27的多聚泛素化和降解中具有生理作用。此外,我们的初步数据表明,Cul 1,SCF E3连接酶的蛋白亚基,在脂肪细胞中被泛素样分子Nedd 8修饰,并且Nedd 8-Cul 1缀合物的程度在生理条件下的G1期进展过程中受到调节。基于这些数据和已发表的文献,我们提出了一个中心假设,即SCF E3连接酶的Nedd 8修饰是一个动态过程,涉及将Nedd 8从其cullin蛋白靶点连接和去除的相反途径,并且这两种途径对于泛素介导的p27蛋白降解和脂肪细胞增生都是必不可少的。我们将从两个方面检验中心假设。第一个探索的生理意义和机制的调节Nedd 8修饰在G1期进展有关E3连接酶活性。第二个决定了CSN作为能够去除Nedd 8的Nedd 8异肽酶的作用以及对细胞SCF活性的影响。这两个目标都通过评估可测试的工作模型来解决连接Nedd 8的附着和去除的机制。我们预测负责添加和去除Nedd 8的途径对于SCF E3连接酶活性、p27泛素化和降解以及脂肪细胞增生是必不可少的。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RON F MORRISON其他文献
RON F MORRISON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RON F MORRISON', 18)}}的其他基金
Regulation of JNK Signaling by Dual Specificity Phosphatases in Adipocytes
脂肪细胞中双特异性磷酸酶对 JNK 信号传导的调节
- 批准号:
7778084 - 财政年份:2010
- 资助金额:
$ 20.43万 - 项目类别:
Nedd8 Regulation of Ubiquitin E3 Ligases in Adipocytes
Nedd8 对脂肪细胞中泛素 E3 连接酶的调节
- 批准号:
6959198 - 财政年份:2005
- 资助金额:
$ 20.43万 - 项目类别:
ORNITHINE DECARBOXYLASE AND ONCOGENIC TRANSFORMATION
鸟氨酸脱羧酶和致癌转化
- 批准号:
2113782 - 财政年份:1996
- 资助金额:
$ 20.43万 - 项目类别:
相似海外基金
MRC TS Award: Regulation of neutrophil functions by cell cycle proteins
MRC TS 奖:细胞周期蛋白调节中性粒细胞功能
- 批准号:
MR/X023087/1 - 财政年份:2023
- 资助金额:
$ 20.43万 - 项目类别:
Fellowship
Cell cycle proteins as key regulators of cardiac chemosensitivity
细胞周期蛋白作为心脏化疗敏感性的关键调节因子
- 批准号:
10353398 - 财政年份:2021
- 资助金额:
$ 20.43万 - 项目类别:
Cell cycle proteins as key regulators of cardiac chemosensitivity
细胞周期蛋白作为心脏化疗敏感性的关键调节因子
- 批准号:
10558622 - 财政年份:2021
- 资助金额:
$ 20.43万 - 项目类别:
Regulation of neutrophil functions by cell cycle proteins
细胞周期蛋白对中性粒细胞功能的调节
- 批准号:
MR/R02149X/1 - 财政年份:2018
- 资助金额:
$ 20.43万 - 项目类别:
Fellowship
Role of Musashi in the regulation of cell cycle proteins
Musashi 在细胞周期蛋白调节中的作用
- 批准号:
DP120100224 - 财政年份:2012
- 资助金额:
$ 20.43万 - 项目类别:
Discovery Projects
Interaction between HIV-1 and cell cycle proteins
HIV-1 和细胞周期蛋白之间的相互作用
- 批准号:
6594793 - 财政年份:2002
- 资助金额:
$ 20.43万 - 项目类别:
REGULATION OF CELL CYCLE PROTEINS DURING ANGIOGENESIS
血管生成过程中细胞周期蛋白的调节
- 批准号:
6497933 - 财政年份:2002
- 资助金额:
$ 20.43万 - 项目类别:
Interaction between HIV-1 and cell cycle proteins
HIV-1 和细胞周期蛋白之间的相互作用
- 批准号:
6608078 - 财政年份:2002
- 资助金额:
$ 20.43万 - 项目类别:














{{item.name}}会员




